Sirtex gets nod for resin microsphere use in Brazil for HCC treatment

By staff writers

September 16, 2022 -- Radiation oncology firm Sirtex Medical said that the Brazilian National Agency of Supplementary Health (ANS) has approved the use of its SIR-Spheres Y-90 resin microspheres for treatment of intermediate and advanced stage hepatocellular carcinoma (HCC).

ANS updated its List of Health Procedures and Events to recommend SIR-Spheres for use in selective internal radiation therapy, according to Sirtex. The Brazilian Health Regulatory Agency (ANVISA) initially approved SIR-Spheres for SIR-Spheres in 2014.

Copyright © 2022

To read this and get access to all of the exclusive content on create a free account or sign-in now.

Member Sign In:
MemberID or Email Address:  
Do you have a password?
No, I want a free membership.
Yes, I have a password:  
Forgot your password?
Sign in using your social networking account:
Sign in using your social networking